Engineering topics

Petersen, Brenden K.

Publications and source records attributed to Petersen, Brenden K..

3 records

DOE OSTI2024

Computationally restoring the potency of a clinical antibody against Omicron

The COVID-19 pandemic underscored the promise of monoclonal antibody-based prophylactic and therapeutic drugs and revealed how quickly viral escape can curtail effective options. When the SARS-CoV-2 Omicron variant emerged in 2021, many antibody drug products lost potency, including Evusheld and its constituent, cilgavimab. Cilgavimab, like its progenitor COV2-2130, is a class 3 antibody that is compatible with other antibodies in combination4 and is challenging to replace with existing approaches. Rapidly modifying such high-value antibodies to restore efficacy against emerging variants is a compelling mitigation strategy. We sought to redesign and renew the efficacy of COV2-2130 against Omicron BA.1 and BA.1.1 strains while maintaining efficacy against the dominant Delta variant. Here we show that our computationally redesigned antibody, 2130-1-0114-112, achieves this objective, simultaneously increases neutralization potency against Delta and subsequent variants of concern, and provides protection in vivo against the strains tested: WA1/2020, BA.1.1 and BA.5. Deep mutational scanning of tens of thousands of pseudovirus variants reveals that 2130-1-0114-112 improves broad potency without increasing escape liabilities. Our results suggest that computational approaches can optimize an antibody to target multiple escape variants, while simultaneously enriching potency. Our computational approach does not require experimental iterations or pre-existing binding data, thus enabling rapid response strategies to address escape variants or lessen escape vulnerabilities.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2022

Moving the needle: Employing deep reinforcement learning to push the boundaries of coarse-grained vaccine models

Highly mutable infectious disease pathogens (hm-IDPs) such as HIV and influenza evolve faster than the human immune system can contain them, allowing them to circumvent traditional vaccination approaches and causing over one million deaths annually. Agent-based models can be used to simulate the complex interactions that occur between immune cells and hm-IDP-like proteins (antigens) during affinity maturation—the process by which antibodies evolve. Compared to existing experimental approaches, agent-based models offer a safe, low-cost, and rapid route to study the immune response to vaccines spanning a wide range of design variables. However, the highly stochastic nature of affinity maturation and vast sequence space of hm-IDPs render brute force searches intractable for exploring all pertinent vaccine design variables and the subset of immunization protocols encompassed therein. To address this challenge, we employed deep reinforcement learning to drive a recently developed agent-based model of affinity maturation to focus sampling on immunization protocols with greater potential to improve the chosen metrics of protection, namely the broadly neutralizing antibody (bnAb) titers or fraction of bnAbs produced. Using this approach, we were able to coarse-grain a wide range of vaccine design variables and explore the relevant design space. Our work offers new testable insights into how vaccines should be formulated to maximize protective immune responses to hm-IDPs and how they can be minimally tailored to account for major sources of heterogeneity in human immune responses and various socioeconomic factors. Our results indicate that the first 3 to 5 immunizations, depending on the metric of protection, should be specially tailored to achieve a robust protective immune response, but that beyond this point further immunizations require only subtle changes in formulation to sustain a durable bnAb response.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2022

Hypothesis testing via AI: Generating physically interpretable models of scientific data with machine learning (Full Technical Report)

Deep learning has demonstrated an exceptional ability to solve complex tasks (an engineering success); however, it has done so at the expense of the ability to generate new knowledge (a scientific failure). We propose an alternative framework—entitled Deep Symbolic Regression (DSR)—in which artificial neural networks (NNs) rapidly generate hypotheses about physical relationships among inputs. This framework bypasses the need to interpret an NN altogether, while still leveraging the representational power of deep learning. The resulting models are tractable mathematical expressions, which are inherently and readily human interpretable and can provide insights into underlying physical phenomena. Further, we fold this methodology into the scientific process by allowing the scientist to directly integrate a priori knowledge and beliefs to accelerate learning. We demonstrate this methodology on symbolic regression—the problem of rediscovering underlying expressions describing a dataset—and achieve state-of-the-art performance across a wide variety of symbolic regression problems. Further, we generalize our DSR framework to apply to the more general class of symbolic optimization problems, in which one seeks to optimize a sequence of symbols or “tokens” under a black-box reward function. Examples of other symbolic optimization problems include neural architecture search and computational antibody design. Our generalized tool, Deep Symbolic Optimization (DSO), has been demonstrated on the task of learning symbolic control policies for reinforcement learning environments, and has been adopted as an enabling capability for computational antibody design.

97 MATHEMATICS AND COMPUTING↗